Genygi Life Sciences

Genastro-1

Manufacturer:	Hetero Labs Limited
Active ingredient:	Anastrazole Tablets IP 1 mg

Adjuvant therapy for early breast cancer with positive hormone receptors in postmenopausal women, including those who have received adjuvant tamoxifen therapy for 2-3 years.

Download Documentation

Disclaimer:

This medical information is intended exclusively for healthcare professionals in India. The products discussed herein may have different labeling and regulatory requirements in other countries.

The information provided on this site is scientific, evidence-based, and intended to address unsolicited medical inquiries in a balanced manner.

For full Prescribing Information, including indications, contraindications, warnings, precautions, and potential adverse events, please submit a medical information request.

This content is not intended as medical advice. Responsibility for patient care rests solely with the healthcare professional, based on their professional license, expertise, and knowledge of the patient.

This website does not engage in the sale or purchase of any medicines.

Genastro-1

Eltrombogen-50

Enzalutagen-40

Gefigen-250

Genzibo-60

Lenagen-25

Pomagen-1

Pomagen-2

Tamoxelle 20

Genygi Life Sciences Private Limited

Genastro-1

Related products

Genygi Life Sciences Private Limited